The upregulation of the BDNF/TrkB/CREB signaling pathway, accompanied by the activation of TrkB and growth factors, can significantly reduce depressive-like behaviors and alleviate depression-induced microscopic changes in the frontal cortex and hippocampus [28]. This evidence concerns the gene NTRK2 and depressive disorder.